The Global Alliance for TB Drug Development

Tweet this page
<
2016
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 09 Jan 2017
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

17,500€

Financial year: Jan 2015 - Dec 2015

Lobbyists (Full time equivalent)

0.5 Fte (2)

Lobbyists with EP accreditation

0

High-level Commission meetings

3

Lobbying Costs over the years

  • Info

    Global Alliance for Tuberculosis Drug Development

    EU Transparency Register

    636752920377-18 First registered on 20 Jan 2016

    Goals / Remit

    TB Alliance is a not-for-profit organization dedicated to the discovery and development of better, faster-acting, and affordable tuberculosis drugs that are available to those who need them.

    Main EU files targeted

    Innovation for global health research and development primarily in Horizon2020 and FP9.

    Address

    Head Office
    40 Wall Street
    24th Floor
    New York 10005
    UNITED STATES
    EU Office
    Square De Meeus, 37
    Bruxelles 1000
    BELGIUM
  • People

    Total lobbyists declared

    2

    Employment timeLobbyists
    25%2

    Lobbyists (Full time equivalent)

    0.5

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    0 accreditations were / are live (in bold) for the selected state of 09 Jan 2017

    Name Start date End Date
    Mr Willo BROCK 30 Aug 2019 29 Aug 2020
    Ms Erin MORTON 24 Feb 2018 23 Feb 2019
    Mr Willo BROCK 20 Jan 2018 19 Jan 2019

    Complementary Information

    None declared

    Person in charge of EU relations

    Mr Willo Brock (Senior Vice President for External Affairs)

    Person with legal responsibility

    Mr Mel Spigelman (President & CEO)

  • Categories

    Category

    III - Non-governmental organisations

    Subcategory

    Non-governmental organisations, platforms and networks and similar

  • Networking

    Affiliation

    None declared

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2015 - Dec 2015

    Lobbying costs for closed financial year

    17,500€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    None

    ACC

    None

    Groups (European Parliament)

    None

    Communication activities

    World TB Day activities around innovation in TB research

    Other activities

    None declared

  • Meetings

    Meetings

    3 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    • Date 14 Oct 2022 Location Brussels
      Subject Global Gateway Strategy and Global Health Strategy
      Cabinet Cabinet of Commissioner Jutta Urpilainen
      Portfolio International Partnerships
      Attending
      • Renaud Savignat (Cabinet member)
    • Date 10 Oct 2018 Location Brussels
      Subject Global Health in Horizon Europe
      Cabinet Cabinet of Commissioner Carlos Moedas
      Portfolio Research, Science and Innovation
      Attending
      • Giulia Del Brenna (Cabinet member)
    • Date 25 Jan 2018 Location Brussels
      Subject EU action to help reduce TB
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Vytenis Andriukaitis (Commissioner)
      • Paula Duarte Gaspar (Cabinet member)
      Other Lobbyists
Download this datacard